250 related articles for article (PubMed ID: 26992727)
41. The effect of time interval of vaginal ring pessary replacement for pelvic organ prolapse on complications and patient satisfaction: A randomised controlled trial.
Tam MS; Lee VYT; Yu ELM; Wan RSF; Tang JSM; He JMY; Lui LKY; Chiu KP; Cheung RYK; Lee KW
Maturitas; 2019 Oct; 128():29-35. PubMed ID: 31561819
[TBL] [Abstract][Full Text] [Related]
42. Successful use of the Gellhorn pessary as a second-line pessary in women with advanced pelvic organ prolapse.
Deng M; Ding J; Ai F; Zhu L
Menopause; 2017 Nov; 24(11):1277-1281. PubMed ID: 28640155
[TBL] [Abstract][Full Text] [Related]
43. Feasibility of using pessaries for treatment of pelvic organ prolapse in rural Nepal.
Robert M; Govan AJ; Lohani U; Uprety A
Int J Gynaecol Obstet; 2017 Mar; 136(3):325-330. PubMed ID: 28099682
[TBL] [Abstract][Full Text] [Related]
44. Predictors for long-term adherence to vaginal pessary in pelvic organ prolapse: a prospective study.
Niigaki DI; Silva RSP; Bortolini MAT; Fitz FF; Castro RA
Int Urogynecol J; 2022 Nov; 33(11):3237-3246. PubMed ID: 35286427
[TBL] [Abstract][Full Text] [Related]
45. Quality of life and vaginal symptoms of postmenopausal women using pessary for pelvic organ prolapse: a prospective study.
Coelho SCA; Marangoni-Junior M; Brito LGO; Castro EB; Juliato CRT
Rev Assoc Med Bras (1992); 2018 Dec; 64(12):1103-1107. PubMed ID: 30569986
[TBL] [Abstract][Full Text] [Related]
46. Vaginal pessary for pelvic organ prolapse: A survey among french gynecological surgeons.
Vardon D; Martin-Lasnel M; Agostini A; Fauvet R; Pizzoferrato AC
J Gynecol Obstet Hum Reprod; 2021 Apr; 50(4):101833. PubMed ID: 32585395
[TBL] [Abstract][Full Text] [Related]
47. Changes of intravaginal microbiota and inflammation after self-replacement ring pessary therapy compared to continuous ring pessary usage for pelvic organ prolapse.
Yoshimura K; Morotomi N; Fukuda K; Kubo T; Taniguchi H
J Obstet Gynaecol Res; 2020 Jun; 46(6):931-938. PubMed ID: 32189434
[TBL] [Abstract][Full Text] [Related]
48. Vaginal pessary continuation in symptomatic pelvic organ prolapse patients with prior hysterectomy.
Ma C; Kang J; Xu T; Zhang Y; Ma Y; Liang S; Hui Y; Wang Y; Zhu L
Menopause; 2020 Oct; 27(10):1148-1154. PubMed ID: 32881830
[TBL] [Abstract][Full Text] [Related]
49. Vaginal evisceration during pessary fitting and treatment with immediate colpocleisis.
Rubin R; Jones KA; Harmanli OH
Obstet Gynecol; 2010 Aug; 116 Suppl 2():496-498. PubMed ID: 20664431
[TBL] [Abstract][Full Text] [Related]
50. A prospective study of pessary use for severe pelvic organ prolapse: 3-year follow-up outcomes.
Li B; Chen Q; Zhang J; Yu C; Zhang L; Chen L
Arch Gynecol Obstet; 2020 May; 301(5):1213-1218. PubMed ID: 32274637
[TBL] [Abstract][Full Text] [Related]
51. The impact of pessary use on bowel symptoms: one-year outcomes.
Brazell HD; Patel M; O'Sullivan DM; Mellen C; LaSala CA
Female Pelvic Med Reconstr Surg; 2014; 20(2):95-8. PubMed ID: 24566213
[TBL] [Abstract][Full Text] [Related]
52. Predictors of unsuccessful pessary fitting in women with prolapse: a cross-sectional study in general practice.
Panman CM; Wiegersma M; Kollen BJ; Burger H; Berger MY; Dekker JH
Int Urogynecol J; 2017 Feb; 28(2):307-313. PubMed ID: 27525693
[TBL] [Abstract][Full Text] [Related]
53. Changes in Prolapse and Urinary Symptoms After Successful Fitting of a Ring Pessary With Support in Women With Advanced Pelvic Organ Prolapse: A Prospective Study.
Ding J; Chen C; Song XC; Zhang L; Deng M; Zhu L
Urology; 2016 Jan; 87():70-5. PubMed ID: 26375847
[TBL] [Abstract][Full Text] [Related]
54. Primary treatment of pelvic organ prolapse: pessary use versus prolapse surgery.
Coolen AWM; Troost S; Mol BWJ; Roovers JPWR; Bongers MY
Int Urogynecol J; 2018 Jan; 29(1):99-107. PubMed ID: 28600758
[TBL] [Abstract][Full Text] [Related]
55. Use of a pessary in treatment of pelvic organ prolapse: quality of life, compliance, and failure at 1-year follow-up.
Ko PC; Lo TS; Tseng LH; Lin YH; Liang CC; Lee SJ
J Minim Invasive Gynecol; 2011; 18(1):68-74. PubMed ID: 21195956
[TBL] [Abstract][Full Text] [Related]
56. Defecatory dysfunction and other clinical variables are predictors of pessary discontinuation.
Dengler EG; Mounsey LA; Gines F; Agha M; Long T; Geller EJ
Int Urogynecol J; 2019 Jul; 30(7):1111-1116. PubMed ID: 30343377
[TBL] [Abstract][Full Text] [Related]
57. Risk factors associated with an unsuccessful pessary fitting trial in women with pelvic organ prolapse.
Clemons JL; Aguilar VC; Tillinghast TA; Jackson ND; Myers DL
Am J Obstet Gynecol; 2004 Feb; 190(2):345-50. PubMed ID: 14981372
[TBL] [Abstract][Full Text] [Related]
58. Long-term compliance of vaginal pessaries: Does stress urinary incontinence matter?
Hsieh MF; Tsai HW; Liou WS; Lo CC; Lin ZH; An YF; Lin HY
Medicine (Baltimore); 2019 Apr; 98(14):e15063. PubMed ID: 30946355
[TBL] [Abstract][Full Text] [Related]
59. Women and healthcare providers' knowledge, attitudes and practice related to pessaries for pelvic organ prolapse: A Systematic review.
Vasconcelos CTM; Silva Gomes ML; Ribeiro GL; Oriá MOB; Geoffrion R; Vasconcelos Neto JA
Eur J Obstet Gynecol Reprod Biol; 2020 Apr; 247():132-142. PubMed ID: 32113060
[TBL] [Abstract][Full Text] [Related]
60. Factors influencing long-term pessary use.
Friedman S; Sandhu KS; Wang C; Mikhail MS; Banks E
Int Urogynecol J; 2010 Jun; 21(6):673-8. PubMed ID: 20062974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
